• Pharma
  • April 17, 2018
  • 318 views
Deep investigation opens unseen overpricing issues of Pharmaceutical firm

FDA may send overpricing notice to the Pharmaceutical firm. While investigating Saurya Pratap case against Medanta for overpricing, officers found the medicines used in the bill had MRP higher than…